Welcome to our dedicated page for Churchill Cap X SEC filings (Ticker: CCCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Churchill Capital Corp X (CCCX) files with the U.S. Securities and Exchange Commission as a blank check company listed on Nasdaq. This SEC filings page allows investors to review the company’s regulatory documents, which are central to understanding its structure as a special purpose acquisition company and its proposed business combination with ColdQuanta, Inc. (Infleqtion).
Key filings for Churchill Capital Corp X include current reports on Form 8-K, which disclose material events. One such Form 8-K describes the Agreement and Plan of Merger and Reorganization among Churchill Capital Corp X, two merger subsidiaries, and ColdQuanta, Inc., and notes the confidential submission of a draft registration statement on Form S-4. Subsequent communications reference the filing of a joint Form S-4 that includes a preliminary proxy statement/prospectus for Churchill Capital Corp X shareholders.
Through this page, users can access the company’s registration statements, proxy materials related to the proposed transaction, and other Exchange Act reports. These documents outline the terms of the business combination, the securities to be issued, and the risk factors associated with the transaction and the combined company. They also provide details on Churchill Capital Corp X’s units, Class A ordinary shares, and warrants listed on Nasdaq.
Stock Titan enhances these filings with AI-powered summaries that explain complex sections in plain language, helping readers interpret items such as merger terms, forward-looking statements, and risk disclosures. As new filings are made available through EDGAR, they are reflected here so that investors can review the latest information on CCCX, the proposed Infleqtion merger, and any subsequent corporate actions.
Use this page to examine Churchill Capital Corp X’s 8-K reports, registration statements on Form S-4, and related proxy and prospectus materials, and to understand how the company’s SPAC structure and planned business combination are documented in its official SEC submissions.
Infleqtion, Inc. has completed its business combination with SPAC Churchill Capital Corp X, converting from a Cayman entity into a Delaware corporation and emerging as a publicly traded quantum technology company. Legacy Infleqtion stockholders received an aggregate 151,804,988 shares of common stock, implying a $1.8 billion equity value at a deemed $10.00 per share.
The deal included a PIPE financing in which investors purchased 12,654,760 shares of common stock for $126.5 million. Immediately after closing, the company had 216,471,927 shares outstanding, with Legacy Infleqtion holders owning 70.1%, Churchill public shareholders 19.1%, the sponsor 5.0% and PIPE investors 5.8%.
Churchill’s former shareholders now hold 24.0% of the company, and Churchill ceased to be a shell company. The combined company will trade on the NYSE under the symbols INFQ and INFQ WS, has adopted new charter documents, board committees and compensation plans, and implemented 2026 equity incentive and employee stock purchase plans.
Infleqtion, Inc. (formerly Churchill Capital Corp X) has filed a Form 25 to remove the listing and registration of its securities from The Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934.
The filing covers the company’s units (each consisting of one Class A ordinary share and one-quarter of one redeemable warrant), its Class A ordinary shares with a par value of $0.0001 per share, and its warrants, where each whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50. The notification is signed on behalf of the company by Chief Executive Officer Matthew Kinsella.
Churchill Capital Corp X shareholders approved its business combination with quantum technology company Infleqtion, along with related proposals including domestication to Delaware, new governance documents, stock issuance, incentive plans, an ESPP and director elections. Over 90% of votes cast supported the transaction.
Redemptions were minimal, with only 37,821 Class A shares redeemed, so Churchill expects to deliver about
Churchill Capital Corp X reported that its shareholders overwhelmingly approved its proposed business combination with Infleqtion, Inc., a quantum sensing and quantum computing company. More than 90% of votes cast supported the deal and related proposals at the extraordinary shareholder meeting.
Redemptions were minimal: holders of 37,821 Class A shares, about 0.09% of the class, redeemed for a pro rata $388,453.90, or roughly $10.27 per share. As a result, the transaction is expected to deliver about $551.4 million of gross proceeds to Infleqtion, including approximately $424.8 million from the trust account and $126.5 million from a previously announced private placement.
Churchill will domesticate from the Cayman Islands to Delaware and be renamed Infleqtion, Inc. The combined company’s common stock and warrants are expected to trade on the NYSE under the symbols “INFQ” and “INFQ WS,” with closing of the transaction targeted for February 13, 2026, subject to customary conditions and NYSE listing requirements.
Barclays PLC filed an amended Schedule 13G reporting beneficial ownership of 1,797,424 shares of Churchill Capital Corp X-A common stock, representing 4.31% of the class as of December 31, 2025.
Barclays has sole voting and dispositive power over all reported shares, with no shared power. The firm states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Churchill Capital Corp X-A.
The filing also notes that Barclays’ ownership is 5 percent or less of the company’s common stock, and identifies Barclays Bank PLC and Barclays Capital Inc as relevant subsidiaries.
Churchill Capital Corp X is advancing its proposed business combination with quantum technology company Infleqtion (ColdQuanta, Inc.), highlighting growth plans and risks. A Benzinga article reprinted here notes that Infleqtion reported $29 million in trailing twelve‑month revenue as of June 30, 2025, plus about $50 million in booked and awarded business. Management emphasizes a more than $300 million pipeline and a strategy to turn pilot deployments into multi‑year contracts, especially in quantum sensing and timing products such as Tiqker, SqyWire and Exaqt. The companies state that proceeds from Infleqtion’s planned public listing are expected to accelerate research and development and deployment capacity. A Form S‑4 registration statement for the transaction was declared effective on January 23, 2026, and shareholders are directed to the definitive proxy statement/prospectus and extensive risk disclosures, including technology, government customer concentration, financing, execution and regulatory uncertainties.
Churchill Capital Corp X is advancing its proposed business combination with quantum technology company Infleqtion (formerly ColdQuanta), a neutral‑atom quantum computing and sensing specialist. The deal values Infleqtion at $1.8 billion and is expected to generate approximately $540 million in gross proceeds, including more than $125 million from a common stock PIPE by existing and new institutional investors.
Infleqtion develops quantum computers, atomic clocks, RF receivers and inertial navigation solutions for government and commercial customers, and has secured multi‑million‑dollar contracts from U.S. defense and energy agencies and NASA. A joint registration statement on Form S‑4 was declared effective on January 23, and Churchill has scheduled a February 12 extraordinary general meeting to vote on the merger. The combination is described as expected to close at the end of the following week, with the combined company operating as “Infleqtion, Inc.” and expected to list on the New York Stock Exchange under the ticker “INFQ.”
Churchill Capital Corp X, a SPAC listed on Nasdaq, plans to move its listing to the New York Stock Exchange in connection with its proposed business combination with quantum technology company Infleqtion. After the deal closes, Churchill will redomicile from the Cayman Islands to Delaware.
Each Class A ordinary share will convert on a one-for-one basis into common stock, and each public warrant will become a warrant for the same number of common shares. Units from the IPO will be split into shares and quarter-warrants and will cease trading on Nasdaq.
Churchill expects Nasdaq trading in its Class A shares, warrants and units to end on February 13, 2026, with the combined company’s common stock and warrants beginning trading on the NYSE on February 17, 2026 under the symbols “INFQ” and “INFQ WS,” subject to completion of the business combination.
Churchill Capital Corp X plans to move its stock market listing from Nasdaq to the New York Stock Exchange in connection with its previously announced business combination with ColdQuanta, Inc. (Infleqtion). The move is contingent on completing the business combination and a re‑domiciling from the Cayman Islands to Delaware.
At closing, each Class A ordinary share will convert one-for-one into common stock, and each public warrant will convert into a warrant for the same number of common shares. Units from the initial public offering will separate into shares and warrants before closing. Trading of the current securities on Nasdaq is expected to end on February 13, 2026, with the new common stock and warrants expected to begin trading on the NYSE on February 17, 2026 under the symbols “INFQ” and “INFQ WS”.